Discover MabDesign

MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.
carl-newton-2C6kAtCXf6U-unsplash

Access our network

Join the MabDesign network to take advantage of all the advantages and opportunities offered.
casey-horner-9vf1uj6i6Ww-unsplash

Develop your skills

Consult and register for our next training courses in order to acquire new expertise.
smartworks-coworking-Uz8THWPXwhI-unsplash

Explore our business services

The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.
arlington-research-kN_kViDchA0-unsplash

Upcoming events

Add your title here

28
Apr.
28-30 April, 2026
Partner Event
28
Apr.
April 28-30 2026
Partner Event
05
May.
May, 5-6 2026
Partner Event
06
May.
May 6-9 2026
Partner Event

Our News

Capture d'écran 2026-03-20 142837

ZOOM ON - THERADIS

26 March 2026
THERADIS PHARMA is a pharmaceutical services company providing comprehensive support for the management of Investigational Products and Biological samples for Phase I to IV clinical studies through its integrated services platform LINCKIA
Capture d'écran 2026-03-20 161725

ZOOM ON - Spegegant

24 March 2026
Our services cover epidemiological and health-economic model development "from scratch“, analysis of existing models, value assessment of health products, development of value arguments, competitive positioning assessment.
Capture d'écran 2026-03-17 103557

ZOOM ON - CERGroupe

17 March 2026
De l'innovation aux données robustes depuis près de 50 ans : CER Groupe délivre bioproduction, précliniques vitro/vivo multi-espèces et bioanalyses sous GLP/ISO/CIR .
Cell Therapies March 26

Cell Therapies

10 March 2026
MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of cell therapies.

OUR BOARD OF DIRECTORS